Emmaus Life Sciences, Inc. Quarterly report [Sections 13 or 15(d)]

Selected Financial Statement - Assets

3 Months Ended

Mar. 31, 2025

NOTE 4 — SELECTED FINANCIAL STATEMENT — ASSETS

Inventories consisted of the following (in thousands):


	March 31, 2025			December 31, 2024
Raw materials and components	$	1,147		$	1,147
Work-in-process		187			184
Finished goods		5,127			5,328
Inventory reserve		(5,024	)		(5,024	)
Total inventories, net	$	1,437		$	1,635

Prepaid expenses and other current assets consisted of the following (in thousands):


	March 31, 2025		December 31, 2024
Prepaid insurance	$	413	$	622
Prepaid expenses		198		272
Other current assets		211		226
Total prepaid expenses and other current assets	$	822	$	1,120

Property and equipment consisted of the following (in thousands):


	March 31, 2025			December 31, 2024
Equipment	$	357		$	357
Leasehold improvements		15			15
Furniture and fixtures		30			30
Total property and equipment		402			402
Less: accumulated depreciation		(361	)		(356	)
Total property and equipment, net	$	41		$	46

For the three months ended March 31, 2025 and 2024, depreciation expense was approximately $5,000 and $6,000, respectively.